CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-06-25 | ZELDIS JEROME B Director | Purchase · Common Stock Warrants | +17,857 | 17,857 | ||
| 2013-06-25 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase | +9,523 | $1.05 | $10K | 59,681 |
| 2013-06-25 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase · Common Stock Warrants | +7,143 | 7,142 | ||
| 2013-06-25 | Brownlie Keith L Director | Purchase | +19,047 | $1.05 | $20K | 19,047 |
| 2013-06-25 | Brownlie Keith L Director | Purchase · Common Stock Warrants | +14,286 | 14,285 | ||
| 2013-06-20 | ZELDIS JEROME B Director | Exercise or conversion | +25,000 | $0.30 | $8K | 25,000 |
| 2013-06-20 | ZELDIS JEROME B Director | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2012-12-20 | CAVAZZA PAOLO 10% owner | Other disposition · Common Stock Warrant (warrant to buy) | −1 | 0 | ||
| 2012-12-20 | CAVAZZA PAOLO 10% owner | Other disposition · Common Stock Warrant (warrant to buy) | −1 | 0 | ||
| 2012-12-20 | CAVAZZA PAOLO 10% owner | Other acquisition · Common Stock Warrant (warrant to buy) | +1 | 1 | ||
| 2012-12-20 | CAVAZZA PAOLO 10% owner | Other disposition · Common Stock Warrant (warrant to buy) | −1 | 0 | ||
| 2012-12-20 | CAVAZZA PAOLO 10% owner | Other acquisition · Common Stock Warrant (warrant to buy) | +1 | 1 | ||
| 2012-12-20 | SIGMA TAU FINANZIARIA SPA 10% owner | Other disposition · Common Stock Warrant (right to buy) | −1 | 0 | ||
| 2012-12-20 | SIGMA TAU FINANZIARIA SPA 10% owner | Other disposition · Common Stock Warrant (right to buy) | −1 | 0 | ||
| 2012-12-20 | SIGMA TAU FINANZIARIA SPA 10% owner | Other acquisition · Common Stock Warrant (right to buy) | +1 | 1 | ||
| 2012-06-21 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2012-06-21 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2012-06-21 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2012-06-21 | Brownlie Keith L Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2012-04-10 | SCHABER CHRISTOPHER J Chairman CEO and President | Purchase | +9,900 | $0.51 | $5K | 50,157 |
Page 13 of 14 · 277 trades